SciRhom

Private

PlaneggHealthcare & Life Scienceshttps://scirhom.com/

Last Round

Series A

Jul 9, 2024

Total Funding Raised

$105.28M

Company Overview

SciRhom is a biotechnology company that develops first-in-class therapeutic antibodies targeting iRhom2 to treat autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

therapeutic antibodybiotechautoimmune diseaseiRhom2drug developmentbiopharmainflammatory diseaseclinical-stage biotechmonoclonal antibodydrug discoverybiologicpreclinical researchtherapeutic targetbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SciRhom Comps

Public and private peers based on sector, stage, and business model.

SciRhom comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SciRhom Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jul 9, 2024
Seed	Nov 30, 2021
Seed	Jan 12, 2021
Seed	Nov 5, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Jan Poth

Managing Director Chief Executive Officer

Executive Team

SciRhom Investors

Notable investors and investment history

SciRhom investors
Investor	Rounds
MIG Capital	Series A
Andera Partners	Series A
MIG AG	Series A
Ventura Ace	Seed
Hadean Ventures	Series A
Wellington Partners	Series A
Bayern Kapital	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 4, 2026
Monthly visitors grew 92% MoM.

View all signals

SciRhom Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SciRhom Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SciRhom's valuation, stock price, and market status.

Firmographic Details

HeadquartersPlanegg

Employee Range17

Year Founded2016

Last FundingJul 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.